One out of every six men...

 is at lifetime risk for prostate cancer. While the disease touches the lives of millions of men and their families, myths and misunderstandings  about prostate cancer are common. 

     Learning about prostate cancer, who's at risk and how to fight it is a crucial first step for anyone facing the disease. The more you know about prostate cancer, the better equipped you are to fight it. We are here to help.

Did you Know?

     Some men who have surgery to treat their prostate cancer will later have a relapse of their disease, usually detected by a rising PSA level. Prior to starting hormonal therapy , some of these men may elect to pursue investigational strategies to delay progression of the tumor. In general, these approaches have little to no side effects and are therefore better tolerated than hormonal therapy. The rationale is to delay progression of the cancer and postpone the use of hormonal therapy, since this is not curative and inevitably leads to hormone-resistant disease. Strategies include vaccines to strengthen the immune system's response to the cancer cells, inhibitors of blood vessel growth, inhibitors of the cancer's ability to spread  such as metalloprotease inhibitors, and agents to change the aggressiveness of the cancer cells. The advantage is the possibility that cancer progression will be delayed, while the disadvantages relate to treatment side effects, which vary from drug to drug. 

     Prostate Cancer Options helps patients make the best decisions by providing up-to-date scientific and technical expertise. After a diagnosis of prostate cancer our objective is to offer effective health solutions with minimal side effects.

    We have provided for you some information to help you better understand prostate cancer as well as prostate health related issues to make your treatment decisions easier.